Four Year Outcomes from the EVOLUT Low Risk Trial

Invited Speaker(s)

• 

  Michael J. Reardon, MD

  Faculty
  Houston Methodist DeBakey Heart & Vascular Center
  Houston, Texas, United States

  Disclosure(s): AstraZeneca; Boston Scientific; Cook Medical; Ethicon; Merck & Co., Inc., Rahway, NJ, USA; Novartis; BMS: Consultant (Ongoing)